Literature DB >> 8581220

Accelerated healing of cardiovascular textiles promoted by an RGD peptide.

K S Tweden1, H Harasaki, M Jones, J M Blevitt, W S Craig, M Pierschbacher, M N Helmus.   

Abstract

Polytetrafluoroethylene (PTFE) and polyethylene terephthalate (Dacron polyester) fabrics are used extensively in cardiovascular devices, e.g. heart valve sewing cuffs and vascular prostheses. While devices containing these fabrics are generally successful, it is recognized that fabrics cause complications prior to tissue ingrowth due to their thrombogenic nature. A surface active synthetic peptide, called PepTite Coating (PepTite), which was modeled after the cell attachment domain of human fibronectin has been marketed as a biocompatible coating. This peptide stimulates cell attachment through the arginine-glycine-aspartic acid (RGD) sequence. Modification of medical implants with PepTite has been shown to promote ingrowth of surrounding cells into the material leading to better tissue integration, reduced inflammation and reduced fibrotic encapsulation. In this study, polyester and PTFE textiles were modified with PepTite. The effectiveness of this coating in enhancing wound healing was investigated in a simple vascular and cardiac valve model. Our results indicate that the RGD-containing peptide, PepTite, promoted the formation of an endothelial-like cell layer on both polyester and PTFE vascular patches in the dog model. PepTite was also found to promote the formation of a significantly thinner neointima (pannus) on polyester as compared to that on its uncoated control. These results were corroborated in the cardiac valve model in which a greater amount of thin pannus and less thrombus were seen on coated polyester sewing cuffs than on control uncoated cuffs. This research shows the promising tissue response to RGD coated textiles and the potential role of this peptide in material passivation via accelerated healing.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8581220

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  5 in total

Review 1.  Implants in bone: part I. A current overview about tissue response, surface modifications and future perspectives.

Authors:  Cornelius von Wilmowsky; Tobias Moest; Emeka Nkenke; Florian Stelzle; Karl Andreas Schlegel
Journal:  Oral Maxillofac Surg       Date:  2013-02-24

2.  Targeted Intraceptor Nanoparticle for Neovascular Macular Degeneration: Preclinical Dose Optimization and Toxicology Assessment.

Authors:  Xiaohui Zhang; Austin Bohner; Sai Bhuvanagiri; Hironori Uehara; Arun Kumar Upadhyay; Lyska L Emerson; Sailaja Bondalapati; Santosh Kumar Muddana; Daniel Fang; Miaoling Li; Zoya Sandhu; Alya Hussain; Lara S Carroll; Michelle Tiem; Bonnie Archer; Uday Kompella; Rajkumar Patil; Balamurali K Ambati
Journal:  Mol Ther       Date:  2017-02-22       Impact factor: 11.454

3.  Characterization of surface modified polyester fabric.

Authors:  Roy Joseph; R Shelma; A Rajeev; C V Muraleedharan
Journal:  J Mater Sci Mater Med       Date:  2008-06-27       Impact factor: 3.896

4.  Altered calcium dynamics in cardiac cells grown on silane-modified surfaces.

Authors:  Melissa S Ravenscroft-Chang; Jayna M Stohlman; Peter Molnar; Anupama Natarajan; Heather E Canavan; Maggie Teliska; Maria Stancescu; Victor Krauthamer; James J Hickman
Journal:  Biomaterials       Date:  2009-10-13       Impact factor: 12.479

5.  Targeted intraceptor nanoparticle therapy reduces angiogenesis and fibrosis in primate and murine macular degeneration.

Authors:  Ling Luo; Xiaohui Zhang; Yoshio Hirano; Puneet Tyagi; Péter Barabás; Hironori Uehara; Tadashi R Miya; Nirbhai Singh; Bonnie Archer; Yureeda Qazi; Kyle Jackman; Subrata K Das; Thomas Olsen; Srinivas R Chennamaneni; Brian C Stagg; Faisal Ahmed; Lyska Emerson; Kristen Zygmunt; Ross Whitaker; Christina Mamalis; Wei Huang; Guangping Gao; Sangly P Srinivas; David Krizaj; Judit Baffi; Jayakrishna Ambati; Uday B Kompella; Balamurali K Ambati
Journal:  ACS Nano       Date:  2013-03-20       Impact factor: 15.881

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.